Cargando…
New Drugs Bringing New Challenges to AML: A Brief Review
The better understanding of the genomic landscape in acute myeloid leukaemia (AML) has progressively paved the way for precision medicine in AML. There is a growing number of drugs with novel mechanisms of action and unique side-effect profiles. This review examines the impact of evolving novel ther...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537004/ https://www.ncbi.nlm.nih.gov/pubmed/34683144 http://dx.doi.org/10.3390/jpm11101003 |